The 2023 AABB international guidelines for red blood cell transfusions: What is new?

TransfusionVolume 64, Issue 4 p. 727-732 COMMENTARY The 2023 AABB international guidelines for red blood cell transfusions: What is new? Monica B. Pagano, Corresponding Author Monica B. Pagano [email protected] orcid.org/0000-0001-5183-6471 Transfusion Medicine, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA AABB Clinical Transfusion Practice Committee, Bethesda, Maryland, USA Correspondence Monica B. Pagano, Transfusion Medicine, Department of Laboratory Medicine and Pathology, Seattle, WA, USA. Email: [email protected]Search for more papers by this authorSimon J. Stanworth, Simon J. Stanworth Department of Haematology, Oxford University Hospitals NHS Trust; NHSBT, Oxford, UK Radcliffe Department of Medicine, Department of Transfusion Medicine, NHS Blood and Transplant, Oxford, UKSearch for more papers by this authorStacey Valentine, Stacey Valentine Department of Pediatrics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USASearch for more papers by this authorRyan Metcalf, Ryan Metcalf orcid.org/0000-0001-6074-7147 AABB Clinical Transfusion Practice Committee, Bethesda, Maryland, USA Department of Pathology, University of Utah, Salt Lake City, Utah, USASearch for more papers by this authorErica M. Wood, Erica M. Wood Department of Haematology, Monash Health, Melbourne, Victoria, Australia Monash University School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia International Society of Blood Transfusion, Amsterdam, NetherlandsSearch for more papers by this authorKaterina Pavenski, Katerina Pavenski Department of Laboratory Medicine and Pathobiology, University of Toronto and St Michael's Hospital–Unity Health Toronto, Toronto, Ontario, Canada International Collaboration for Transfusion Medicine Guidelines, British Columbia, CanadaSearch for more papers by this authorJill Cholette, Jill Cholette Department of Pediatrics, University of Rochester, Golisano Children's Hospital, Rochester, New York, USASearch for more papers by this authorCynthia So-Osman, Cynthia So-Osman orcid.org/0000-0003-4151-2865 Department of Unit Transfusion Medicine (UTG), Sanquin Blood Bank, Amsterdam, the Netherlands Department Hematology, Erasmus Medical Center, Rotterdam, the Netherlands European Haematology Association, Transfusion-Specialized Working GroupSearch for more papers by this authorJeffrey L. Carson, Jeffrey L. Carson orcid.org/0000-0001-5466-2833 Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USASearch for more papers by this author Monica B. Pagano, Corresponding Author Monica B. Pagano [email protected] orcid.org/0000-0001-5183-6471 Transfusion Medicine, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA AABB Clinical Transfusion Practice Committee, Bethesda, Maryland, USA Correspondence Monica B. Pagano, Transfusion Medicine, Department of Laboratory Medicine and Pathology, Seattle, WA, USA. Email: [email protected]Search for more papers by this authorSimon J. Stanworth, Simon J. Stanworth Department of Haematology, Oxford University Hospitals NHS Trust; NHSBT, Oxford, UK Radcliffe Department of Medicine, Department of Transfusion Medicine, NHS Blood and Transplant, Oxford, UKSearch for more papers by this authorStacey Valentine, Stacey Valentine Department of Pediatrics, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USASearch for more papers by this authorRyan Metcalf, Ryan Metcalf orcid.org/0000-0001-6074-7147 AABB Clinical Transfusion Practice Committee, Bethesda, Maryland, USA Department of Pathology, University of Utah, Salt Lake City, Utah, USASearch for more papers by this authorErica M. Wood, Erica M. Wood Department of Haematology, Monash Health, Melbourne, Victoria, Australia Monash University School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia International Society of Blood Transfusion, Amsterdam, NetherlandsSearch for more papers by this authorKaterina Pavenski, Katerina Pavenski Department of Laboratory Medicine and Pathobiology, University of Toronto and St Michael's Hospital–Unity Health Toronto, Toronto, Ontario, Canada International Collaboration for Transfusion Medicine Guidelines, British Columbia, CanadaSearch for more papers by this authorJill Cholette, Jill Cholette Department of Pediatrics, University of Rochester, Golisano Children's Hospital, Rochester, New York, USASearch for more papers by this authorCynthia So-Osman, Cynthia So-Osman orcid.org/0000-0003-4151-2865 Department of Unit Transfusion Medicine (UTG), Sanquin Blood Bank, Amsterdam, the Netherlands Department Hematology, Erasmus Medical Center, Rotterdam, the Netherlands European Haematology Association, Transfusion-Specialized Working GroupSearch for more papers by this authorJeffrey L. Carson, Jeffrey L. Carson orcid.org/0000-0001-5466-2833 Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USASearch for more papers by this author First published: 21 February 2024 https://doi.org/10.1111/trf.17764 Monica B. Pagano and Simon J. Stanworth contributed equally to this work. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Carson JL, Stanworth SJ, Guyatt G, Valentine S, Dennis J, Bakhtary S, et al. Red blood cell transfusion: 2023 AABB international guidelines. JAMA. 2023; 330: 1892–1902. 10.1001/jama.2023.12914 PubMedGoogle Scholar 2Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med. 2012; 157: 49–58. 10.7326/0003-4819-157-1-201206190-00429 PubMedWeb of Science®Google Scholar 3Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA. 2016; 316: 2025–2035. 10.1001/jama.2016.9185 PubMedWeb of Science®Google Scholar 4Alexander J, Cifu AS. Transfusion of red blood cells. JAMA. 2016; 316: 2038–2039. 10.1001/jama.2016.12870 PubMedWeb of Science®Google Scholar 5Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017; 34: 332–395. 10.1097/EJA.0000000000000630 PubMedWeb of Science®Google Scholar 6Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R, et al. Patient blood management: recommendations from the 2018 Frankfurt consensus conference. JAMA. 2019; 321: 983–997. 10.1001/jama.2019.0554 PubMedWeb of Science®Google Scholar 7Van Remoortel H, De Buck E, Dieltjens T, Pauwels NS, Compernolle V, Vandekerckhove P. Methodologic quality assessment of red blood cell transfusion guidelines and the evidence base of more restrictive transfusion thresholds. Transfusion. 2016; 56: 472–480. 10.1111/trf.13385 PubMedWeb of Science®Google Scholar 8Simancas-Racines D, Montero-Oleas N, Vernooij RWM, Arevalo-Rodriguez I, Fuentes P, Gich I, et al. Quality of clinical practice guidelines about red blood cell transfusion. J Evidence Based Med. 2019; 12: 113–124. 10.1111/jebm.12330 PubMedGoogle Scholar 9Pavenski K, Stanworth S, Fung M, Wood EM, Pink J, Murphy MF, et al. Quality of evidence-based guidelines for transfusion of red blood cells and plasma: a systematic review. Transfus Med Rev. 2018; 32: 135–143. 10.1016/j.tmrv.2018.05.004 Web of Science®Google Scholar 10Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011; 64: 383–394. 10.1016/j.jclinepi.2010.04.026 PubMedWeb of Science®Google Scholar 11Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999; 340: 409–417. 10.1056/NEJM199902113400601 CASPubMedWeb of Science®Google Scholar 12Valentine SL, Bembea MM, Muszynski JA, Cholette JM, Doctor A, Spinella PC, et al. Consensus recommendations for RBC transfusion practice in critically ill children from the pediatric critical care transfusion and anemia expertise initiative. Pediatr Crit Care Med. 2018; 19: 884–898. 10.1097/PCC.0000000000001613 PubMedWeb of Science®Google Scholar 13Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, et al. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2021; 12:CD002042. PubMedWeb of Science®Google Scholar 14Pagano MB, Dennis JA, Idemudia OM, Stanworth SJ, Carson JL. An analysis of quality of life and functional outcomes as reported in randomized trials for red cell transfusions. Transfusion. 2023; 63: 2032–2039. 10.1111/trf.17540 PubMedWeb of Science®Google Scholar 15DeZern AE, Williams K, Zahurak M, Hand W, Stephens RS, King KE, et al. Red blood cell transfusion triggers in acute leukemia: a randomized pilot study. Transfusion. 2016; 56: 1750–1757. 10.1111/trf.13658 CASPubMedWeb of Science®Google Scholar 16Tay J, Allan DS, Chatelain E, Coyle D, Elemary M, Fulford A, et al. Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III. Noninferiority Trial J Clin Oncol. 2020; 38: 1463–1473. 10.1200/JCO.19.01836 PubMedWeb of Science®Google Scholar 17Jansen AJG, van den Bosch J, Te Boekhorst PAW, Schipperus MR, Beckers EAM. Results of the prematurely terminated TEMPLE randomized controlled trial in patients with myelodysplastic syndrome: liberal versus restrictive red blood cell transfusion threshold. Transfusion. 2020; 60: 879–881. 10.1111/trf.15708 CASPubMedWeb of Science®Google Scholar 18Stanworth SJ, Killick S, McQuilten ZK, Karakantza M, Weinkove R, Smethurst H, et al. Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial. Br J Haematol. 2020; 189: 279–290. 10.1111/bjh.16347 PubMedWeb of Science®Google Scholar 19Webert KE, Cook RJ, Couban S, Carruthers J, Lee KA, Blajchman MA, et al. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion. 2008; 48: 81–91. 10.1111/j.1537-2995.2007.01485.x CASPubMedWeb of Science®Google Scholar 20Yakymenko D, Frandsen KB, Christensen IJ, Norgaard A, Johansson PI, Daugaard G, et al. Randomised feasibility study of a more liberal haemoglobin trigger for red blood cell transfusion compared to standard practice in anaemic cancer patients treated with chemotherapy. Transfus Med. 2018; 28: 208–215. 10.1111/tme.12439 CASPubMedWeb of Science®Google Scholar 21Bergamin FS, Almeida JP, Landoni G, Galas F, Fukushima JT, Fominskiy E, et al. Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial. Crit Care Med. 2017; 45: 766–773. 10.1097/CCM.0000000000002283 PubMedWeb of Science®Google Scholar 22Lacroix J, Hebert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007; 356: 1609–1619. 10.1056/NEJMoa066240 CASPubMedWeb of Science®Google Scholar 23Cholette JM, Powers KS, Alfieris GM, Angona R, Henrichs KF, Masel D, et al. Transfusion of cell saver salvaged blood in neonates and infants undergoing open heart surgery significantly reduces RBC and coagulant product transfusions and donor exposures: results of a prospective, randomized, clinical trial. Pediatr Crit Care Med. 2013; 14: 137–147. 10.1097/PCC.0b013e31826e741c PubMedWeb of Science®Google Scholar 24Cholette JM, Swartz MF, Rubenstein J, Henrichs KF, Wang H, Powers KS, et al. Outcomes using a conservative versus Liberal red blood cell transfusion strategy in infants requiring cardiac operation. Ann Thorac Surg. 2017; 103: 206–214. 10.1016/j.athoracsur.2016.05.049 PubMedWeb of Science®Google Scholar 25de Gast-Bakker DH, de Wilde RB, Hazekamp MG, Sojak V, Zwaginga JJ, Wolterbeek R, et al. Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. Intensive Care Med. 2013; 39: 2011–2019. 10.1007/s00134-013-3085-7 PubMedWeb of Science®Google Scholar 26Raasveld SJ, de Bruin S, Reuland MC, van den Oord C, Schenk J, Aubron C, et al. PUTSG. Red blood cell transfusion in the intensive Care unit. JAMA. 2023; 330: 1852–1861. 10.1001/jama.2023.20737 CASPubMedWeb of Science®Google Scholar 27Free RJ, Sapiano MRP, Chavez Ortiz JL, Stewart P, Berger J, Basavaraju SV. Continued stabilization of blood collections and transfusions in the United States: findings from the 2021 National Blood Collection and Utilization Survey. Transfusion. 2023; 63(Suppl 4): S8–S18. 10.1111/trf.17360 PubMedGoogle Scholar 28Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010; 304: 1559–1567. 10.1001/jama.2010.1446 CASPubMedWeb of Science®Google Scholar 29Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011; 365: 2453–2462. 10.1056/NEJMoa1012452 CASPubMedWeb of Science®Google Scholar 30So-Osman C, Nelissen R, Brand R, Faber F, Slaa RT, Stiggelbout A, et al. The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study. Blood Transfus. 2013; 11: 289–295. PubMedWeb of Science®Google Scholar 31Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013; 368: 11–21. 10.1056/NEJMoa1211801 CASPubMedWeb of Science®Google Scholar 32Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink-Bot ML, Uyl-de Groot CA, et al. Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG. 2014; 121: 1005–1014. 10.1111/1471-0528.12531 CASPubMedWeb of Science®Google Scholar 33Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014; 371: 1381–1391. 10.1056/NEJMoa1406617 CASPubMedWeb of Science®Google Scholar 34Jairath V, Kahan BC, Gray A, Dore CJ, Mora A, James MW, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet. 2015; 386: 137–144. 10.1016/S0140-6736(14)61999-1 PubMedWeb of Science®Google Scholar 35Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015; 372: 997–1008. 10.1056/NEJMoa1403612 CASPubMedWeb of Science®Google Scholar 36Koch CG, Sessler DI, Mascha EJ, Sabik JF 3rd, Li L, Duncan AI, et al. A randomized clinical trial of red blood cell transfusion triggers in cardiac surgery. Ann Thorac Surg. 2017; 104: 1243–1250. 10.1016/j.athoracsur.2017.05.048 PubMedWeb of Science®Google Scholar 37Mazer CD, Whitlock RP, Fergusson DA, Hall J, Belley-Cote E, Connolly K, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017; 377: 2133–2144. 10.1056/NEJMoa1711818 PubMedWeb of Science®Google Scholar 38Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, Cachanado M, Durand-Zaleski I, et al. Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with Acute myocardial infarction and anemia: the REALITY randomized clinical trial. JAMA. 2021; 325: 552–560. 10.1001/jama.2021.0135 CASPubMedWeb of Science®Google Scholar 39Carson JL, Brooks MM, Hebert PC, Goodman SG, Bertolet M, Glynn SA, et al. Restrictive or liberal transfusion strategy in myocardial infarction and anemia. N Engl J Med. 2023; 389:2446–2456. 10.1056/NEJMoa2307983 PubMedWeb of Science®Google Scholar Volume64, Issue4April 2024Pages 727-732 ReferencesRelatedInformation